Medication for Addiction Treatment During COVID-19
As overdose rates rise, we need addiction treatment in hospitals now more than ever. This guidance outlines how to implement medication for addiction treatment (MAT) during predicted COVID-19 surges.
New HHS Practice Guidelines
Here’s the most important takeaway of the “HHS Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder”: All prescribers with a valid state license and DEA can register for an X wavier without mandatory training.
Blueprint for Hospital Opioid Use Disorder Treatment
This comprehensive resource is scalable for any health system, based on our model implemented at diverse sites that demonstrate feasibility at large and small, public and private, urban, and rural hospitals.
Substance Use Navigator Training 101
24 Jun 2021, 11:00 am
Leading Change in Hospital Culture (Session 5)
One of our favorite speakers, Charles Hawthorne from the National Harm Reduction Coalition will share strategies to create a culture of harm reduction by changing language about drug use, advancing for equity, and reducing harm to communities of color from drug use. Join us for this thoughtful, well-informed discussion to help you create a supportive environment for substance use disorder treatment, culture, and connection in your hospital.
CA Bridge is CADTP approved provider (CADTP Provider #216). Training sessions are one hour and approved for 1 continuing education credit. Contact SUN@cabridge.org for more information.